WASHINGTON — The rising popularity of prediction market event contracts tied to sensitive healthcare milestones—including clinical drug trials and Food and Drug Administration regulatory decisions—has officially triggered a sharp legislative pushback. According to a letter obtained first by CNBC, two prominent Democratic senators are demanding answers from federal health officials regarding the potential risks these […]